Accretion Pharmaceuticals Limited — Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Accretion Pharmaceuticals Limited has submitted its quarterly compliance report to the stock exchanges. This document confirms that the company is not required to comply with the stricter corporate governance norms applicable to larger listed entities. This status is typically maintained by smaller companies with a specific market capitalization threshold.

This disclosure is a routine regulatory requirement for listed companies. It ensures transparency and keeps investors informed about the company's governance structure. Since the report is about a procedural submission rather than a change in business operations, it does not directly impact the company's financial performance or market valuation at this time.

Investors should monitor Accretion's future filings for any updates regarding its compliance status. If the company's market capitalization crosses the regulatory threshold in the future, it will be required to adopt enhanced corporate governance practices. For now, this news serves as a standard administrative update.